27.52
price down icon1.61%   -0.45
after-market Dopo l'orario di chiusura: 27.51 -0.010 -0.04%
loading

Apellis Pharmaceuticals Inc Azioni (APLS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
7.01%
178.49
166.80 212.53 196.83 199.69
Operating Expenses
15.33%
211.78
250.12 238.69 244.11 229.13
Benefits Costs and Expenses
14.88%
220.18
258.68 248.59 253.68 237.23
Costs And Expenses
14.88%
220.18
258.68 248.59 253.68 237.23
Operating Income/Loss
60.05%
-33.29
-83.33 -26.16 -47.28 -29.44
Income/Loss From Continuing Operations Before Tax
54.63%
-41.69
-91.88 -36.07 -56.85 -37.54
Income Tax Expense/Benefit
36.66%
0.466
0.341 0.286 0.592 0.114
Income/Loss From Continuing Operations After Tax
54.30%
-42.15
-92.22 -36.35 -57.45 -37.66
Net Income/Loss
54.30%
-42.15
-92.22 -36.35 -57.45 -37.66
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.46%
126.02
125.45 0.207 124.23 123.90
Diluted Average Shares
0.46%
126.02
125.45 0.207 124.23 123.90
Basic Earnings Per Share
55.41%
-0.33
-0.74 -0.29 -0.46 -0.30
Diluted Earnings Per Share
55.41%
-0.33
-0.74 -0.29 -0.46 -0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.31
price down icon 1.38%
$84.76
price down icon 0.33%
$26.27
price up icon 0.27%
$105.07
price down icon 5.24%
$128.32
price down icon 2.70%
biotechnology ONC
$308.63
price down icon 1.61%
Capitalizzazione:     |  Volume (24 ore):